COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A ‘two-for’ option

Moderna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3 clinical trials, mRNA-1083 achieved a better immune response than other vaccines. Read More in FOX News.   Read More in Red Pill NOWlej.